台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

PD08-5: miR-375 suppresses upper tract urothelial carcinoma cell migration and invasion via targeting Derlin-1

2021-05-24 • 觀看: 1403 • 回應: 0 • doc
PD08-4: Partial cystectomy after neoadjuvant chemotherapy for muscle invasive bladder cancer

2021-05-24 • 觀看: 1883 • 回應: 0 • doc
PD08-3: Long non-coding RNA mediates cisplatin and gemcitabine resistance in upper tract urothelial carcinoma cells by sponging of miR-31

2021-05-24 • 觀看: 1492 • 回應: 0 • doc
PD08-2: Treatment outcome and FGFR alteration rate in unresectable locally advanced or metastatic urothelial cancer in Taiwan

2021-05-24 • 觀看: 1949 • 回應: 0 • doc
PD08-1: Can ERBT take place of the importance of traditional TURBt?

2021-05-24 • 觀看: 2302 • 回應: 0 • doc
PD07-6: Experience with modified Makuuchi incision in the surgical treatment for huge retroperitoneal tumor

2021-05-20 • 觀看: 1931 • 回應: 0 • doc
PD07-5: Retrospective analysis of Hepatocellular carcinoma with adrenal metastasis treatment and prognosis – VGTCH experience

2021-05-20 • 觀看: 1520 • 回應: 0 • doc
PD07-4: Hsa-mir-34a, as a novel autophagy regulator, inhibits STX-17-mediated fusion of autophagosomes with lysosomes

2021-05-20 • 觀看: 1783 • 回應: 0 • doc
PD07-3: Tumor characteristics and survival outcomes of renal cell carcinoma during the past decade in Taiwanese population: A dual-center retrospective study

2021-05-20 • 觀看: 1605 • 回應: 0 • doc
PD07-2: The mTOR pathway expression of three types of renal angiomyolipoma

2021-05-20 • 觀看: 1778 • 回應: 0 • doc
PD07-1: Automated differentiation of benign and malignant renal tumors on computed tomography using artificial intelligence

2021-05-20 • 觀看: 1509 • 回應: 0 • doc
PD06-6: External validation of solomon-greenwell nomogram for diagnosing female bladder outlet obstruction

2021-05-20 • 觀看: 1682 • 回應: 0 • doc

Prev
691
692
693
694
695
696
697
698
699
700
Next
/ 1262